144 related articles for article (PubMed ID: 10669806)
1. [Pretreatment of organophosphate poisoning: potential interests of huperzine A].
Lallement G
Ann Pharm Fr; 2000 Jan; 58(1):13-7. PubMed ID: 10669806
[TBL] [Abstract][Full Text] [Related]
2. [Advances on study of organophosphate poisoning prevented by Huperzine A].
Liu L; Sun JX
Wei Sheng Yan Jiu; 2005 Mar; 34(2):224-6. PubMed ID: 15952670
[TBL] [Abstract][Full Text] [Related]
3. Current understanding of the application of pyridinium oximes as cholinesterase reactivators in treatment of organophosphate poisoning.
Jokanović M; Stojiljković MP
Eur J Pharmacol; 2006 Dec; 553(1-3):10-7. PubMed ID: 17109842
[TBL] [Abstract][Full Text] [Related]
4. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
[TBL] [Abstract][Full Text] [Related]
5. [Study on antidote therapy of percutaneous organophosphate poisoning in rats].
Oldiges H
Arzneimittelforschung; 1971 Jul; 21(7):1028-30. PubMed ID: 5109489
[No Abstract] [Full Text] [Related]
6. [Huperzine a: an acetylcholinesterase inhibitor with high pharmacological potential].
Pilotaz F; Masson P
Ann Pharm Fr; 1999 Sep; 57(5):363-73. PubMed ID: 10520506
[TBL] [Abstract][Full Text] [Related]
7. [Engineering of catalytic bioscavengers of organophosphorus compounds].
Masson P; Nachon F; Rochu D
Bull Acad Natl Med; 2007 Jan; 191(1):95-111; discussion 112. PubMed ID: 17645110
[TBL] [Abstract][Full Text] [Related]
8. [Current viewpoints in alkylphosphate poisoning. Biochemical findings, symptoms and therapy].
Okonek S
Internist (Berl); 1975 Mar; 16(3):123-30. PubMed ID: 1093993
[No Abstract] [Full Text] [Related]
9. [Prevention, diagnosis and treatment of poisoning with pesticides, derivatives of organophosphorus compounds and carbamates].
Kontek M; Paradowski S
Pol Tyg Lek; 1974 Feb; 29(8):333-5. PubMed ID: 4592843
[No Abstract] [Full Text] [Related]
10. Review of the value of huperzine as pretreatment of organophosphate poisoning.
Lallement G; Baille V; Baubichon D; Carpentier P; Collombet JM; Filliat P; Foquin A; Four E; Masqueliez C; Testylier G; Tonduli L; Dorandeu F
Neurotoxicology; 2002 May; 23(1):1-5. PubMed ID: 12164543
[TBL] [Abstract][Full Text] [Related]
11. [Antidose therapy for organophosphate poisoning].
Iseki K
Chudoku Kenkyu; 2008 Apr; 21(2):151-9. PubMed ID: 18516940
[No Abstract] [Full Text] [Related]
12. [Modern problems of the pharmacotherapy of occupational poisonings].
Ashbel' SI
Gig Tr Prof Zabol; 1979 Aug; (8):5-8. PubMed ID: 385452
[No Abstract] [Full Text] [Related]
13. Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds.
Eckert S; Eyer P; Mückter H; Worek F
Biochem Pharmacol; 2006 Jul; 72(3):344-57. PubMed ID: 16780806
[TBL] [Abstract][Full Text] [Related]
14. [Research progress in experimental therapeutic drugs for acute organophosphate poisoning].
Zhu QH; Huang JX
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2005 Apr; 23(2):142-3. PubMed ID: 16105463
[No Abstract] [Full Text] [Related]
15. Adamantyl tenocyclidines--adjuvant therapy in poisoning with organophosphorus compounds and carbamates.
Skare D; Radić B; Lucić A; Peraica M; Domijan AM; Milković-Kraus S; Bradamante V; Jukić I
Arch Toxicol; 2002 Apr; 76(3):173-7. PubMed ID: 11967623
[TBL] [Abstract][Full Text] [Related]
16. [Fulminant coma as the first manifestation of organophosphate poisoning].
Rodríguez-Borregán JC; Miñambres E; Tejero MA; Rebollo M
Neurologia; 2002 Mar; 17(3):173-5. PubMed ID: 11927111
[No Abstract] [Full Text] [Related]
17. Different toxidynamic aspects of organophosphate poisoning.
Bajgar J
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1972; 15(5):471-83. PubMed ID: 4522059
[No Abstract] [Full Text] [Related]
18. Pharmacologic prophylaxis against nerve agent poisoning.
Layish I; Krivoy A; Rotman E; Finkelstein A; Tashma Z; Yehezkelli Y
Isr Med Assoc J; 2005 Mar; 7(3):182-7. PubMed ID: 15792266
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic effectiveness of esterase reactivators in organophosphate poisoning and its limits].
Jakl A; Tulach J
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1971; 14(2):153-63. PubMed ID: 5289893
[No Abstract] [Full Text] [Related]
20. Comparison of two pre-exposure treatment regimens in acute organophosphate (paraoxon) poisoning in rats: tiapride vs. pyridostigmine.
Petroianu GA; Hasan MY; Nurulain SM; Arafat K; Sheen R; Nagelkerke N
Toxicol Appl Pharmacol; 2007 Mar; 219(2-3):235-40. PubMed ID: 17056080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
